Why I’m Excited About Aducanumab (Aduhelm)!
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s – Aducanumab (brand named, Aduhelm). He ends off …
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s – Aducanumab (brand named, Aduhelm). He ends off …
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman speaks with Dr. Marwan Sabbagh, clinical and research leader at the Cleveland Clinic’s Lou Ruvo Center for Brain Health. He …
It’s been 18 years since the last drug was approved for Alzheimer’s, but on Monday, June 7, 2021, the FDA gave “Accelerated Approval” to Biogen’s novel medication, Aducanumab (“Aduhelm”). The …
Aducanumab – Is this the end of Alzheimer’s? Not just yet… Read More »